Suchergebnisse - "Glycemic Control methods"

Effect of Adherence to Oral Semaglutide on Glycemic Control in People With Type 2 Diabetes Treated With Metformin: Protocol for an Open-Label Clinical Trial

Autoren: Nynne Sophie Holdt-Caspersen Claus Dethlefsen Ole Hejlesen et al.

Quelle: Holdt-Caspersen, N S, Dethlefsen, C, Hejlesen, O, Christiansen, E, Hangaard, S, Vestergaard, P & Jensen, M H 2025, 'Effect of Adherence to Oral Semaglutide on Glycemic Control in People With Type 2 Diabetes Treated With Metformin : Protocol for an Open-Label Clinical Trial', JMIR Research Protocols, vol. 14, e64899. https://doi.org/10.2196/64899

Schlagwörter: Adult, Male, Diabetes Mellitus, Type 2/drug therapy, Denmark, Glucagon-Like Peptides/administration & dosage, Administration, Oral, Middle Aged, Hypoglycemic Agents/administration & dosage, Medication Adherence, Blood Glucose/drug effects, Glucagon-Like Peptide 1, Humans, Glycated Hemoglobin/analysis, Metformin/therapeutic use, Female, Glycemic Control/methods, Prospective Studies, Aged

Dateibeschreibung: application/pdf

The intelligent diabetes telemonitoring using decision support to treat patients on insulin therapy (DiaTRUST) trial: study protocol for a randomized controlled trial

Autoren: Thomsen, Camilla H N Nørlev, Jannie T D Hangaard, Stine et al.

Quelle: Trials
Trials, Vol 25, Iss 1, Pp 1-11 (2024)
Thomsen, C H N, Nørlev, J T D, Hangaard, S, Jensen, M H, Hejlesen, O, Cohen, S R, Kofoed-Enevoldsen, A, Kristensen, S N S, Aradóttir, T B, Kaas, A, Vestergaard, P & Kronborg, T 2024, 'The intelligent diabetes telemonitoring using decision support to treat patients on insulin therapy (DiaTRUST) trial : study protocol for a randomized controlled trial', Trials, vol. 25, no. 1, 744. https://doi.org/10.1186/s13063-024-08588-7

Schlagwörter: Blood Glucose, Telemonitoring, Medicine (General), Diabetes Mellitus, Type 2/drug therapy, Time Factors, Hypoglycemic Agents/therapeutic use, Glycemic Control, Fitness Trackers, Glycated Hemoglobin/metabolism, Study Protocol, R5-920, Blood Glucose Self-Monitoring/methods, Humans, Insulin, Hypoglycemic Agents, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, Glycated Hemoglobin, Blood Glucose/metabolism, Blood Glucose Self-Monitoring, Type 2 diabetes, Clinical decision support, Middle Aged, Decision Support Systems, Clinical, Telemedicine, Treatment Outcome, Diabetes Mellitus, Type 2, Insulin therapy, Glycemic Control/methods, Insulin/administration & dosage, Biomarkers/blood, Biomarkers, Diabetes care

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39511648
https://doaj.org/article/e5cbb1dfaf614af6a8564c04c28c2b5d
https://vbn.aau.dk/ws/files/752234613/s13063-024-08588-7.pdf
https://vbn.aau.dk/da/publications/ad9e28fc-75e1-4c12-9d6e-3886bad3c465
https://doi.org/10.1186/s13063-024-08588-7
http://www.scopus.com/inward/record.url?scp=85209106627&partnerID=8YFLogxK

Glycaemic control and insulin therapy are significant confounders of the obesity paradox in patients with heart failure and diabetes mellitus

Autoren: Hanna Fröhlich Anna Bossmeyer Syed Kazmi et al.

Quelle: Clin Res Cardiol

Schlagwörter: Male, Blood Glucose, Glycemic Control, Body Mass Index, Heart failure, Aged [MeSH], Glycemic Control/methods [MeSH], Risk Factors [MeSH], Insulin/therapeutic use [MeSH], Stroke Volume/physiology [MeSH], Germany/epidemiology [MeSH], Diabetes Mellitus/epidemiology [MeSH], Mortality, Male [MeSH], Obesity/epidemiology [MeSH], Diabetes Mellitus/drug therapy [MeSH], Hypoglycemic Agents/therapeutic use [MeSH], Female [MeSH], Survival Rate/trends [MeSH], Diabetes mellitus, Heart Failure/drug therapy [MeSH], Heart Failure/physiopathology [MeSH], Humans [MeSH], Obesity Paradox [MeSH], Middle Aged [MeSH], Obesity/complications [MeSH], Body Mass Index [MeSH], Glycated Hemoglobin/metabolism [MeSH], Reverse epidemiology, Obesity paradox, Original Paper, Blood Glucose/metabolism [MeSH], Blood Glucose/drug effects [MeSH], Registries [MeSH], Heart Failure/mortality [MeSH], Risk Factors, Germany, Diabetes Mellitus, Humans, Insulin, Hypoglycemic Agents, Obesity, Registries, Aged, 2. Zero hunger, Heart Failure, Glycated Hemoglobin, Stroke Volume, Middle Aged, 3. Good health, Survival Rate, Female, Obesity Paradox

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/37608126
https://repository.publisso.de/resource/frl:6524806

Effect of intensive nutrition training, education and support versus standard therapy in reducing the need for insulin therapy in gestational diabetes (INTENSE-GDM): a protocol for a randomised controlled single-centre trial in Denmark

Autoren: Bettina Ewers Martin B Blond Louise Kelstrup et al.

Quelle: BMJ Open
BMJ Open, Vol 15, Iss 2 (2025)

Schlagwörter: Adult, Nutrition and Metabolism, Patient Education as Topic/methods, Denmark, Diabetes, Gestational/therapy, Hypoglycemic Agents/therapeutic use, Glycemic Control, Nutrition Therapy/methods, Diabetes, Gestational, Patient Education as Topic, Pregnancy, Insulin/therapeutic use, Medicine, Humans, Insulin, Hypoglycemic Agents, Female, Glycemic Control/methods, Nutrition Therapy, Randomized Controlled Trials as Topic

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/39961720
https://doaj.org/article/402f17fccf7849279b0bf2ce2c956117

Cocoa flavanol supplementation in optimizing post-exercise glycemic control in rats with normoglycemia or diabetes mellitus: findings from the ECODIA study: findings from the ECODIA study

Autoren: Bruno Pereira Melo Joyce Camilla Cruz de Oliveira Aline Cruz Zacarias et al.

Weitere Verfasser: Bruno Pereira Melo Joyce Camilla Cruz de Oliveira Aline Cruz Zacarias et al.

Quelle: Arch Endocrinol Metab
Archives of Endocrinology and Metabolism, Vol 68 (2024)

Schlagwörter: Male, Blood Glucose, obesity, Flavonols, [SDV]Life Sciences [q-bio], Glycemic Control, Flavonols/pharmacology, Diseases of the endocrine glands. Clinical endocrinology, RATS, Diabetes Mellitus, Experimental, dietary supplements, Blood Glucose/drug effects, Physical Conditioning, Animal/physiology, physical exercise, Physical Conditioning, Animal, Animals, Lactic Acid, glucose, Rats, Wistar, Chocolate, polyphenols, Cacao, Diabetes, Diabetes Mellitus, Type 1/blood, Lactic Acid/blood, RC648-665, Rats, [SDV] Life Sciences [q-bio], Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Cacao/chemistry, Dietary Supplements, Medicine, Original Article, Glycemic Control/methods, Diabetes Mellitus, Experimental/blood, Diabetes Mellitus, Type 2/blood

Dateibeschreibung: application/pdf

Zugangs-URL: https://pubmed.ncbi.nlm.nih.gov/40215327
https://doaj.org/article/be75ab38c4494c1f84d40aa69736a1df
https://biblio.vub.ac.be/vubir/(6423835e-9c92-40c6-a480-8238f6815f0e).html
https://hal.univ-lille.fr/hal-04872837v1
https://hal.univ-lille.fr/hal-04872837v1/document
https://doi.org/10.20945/2359-4292-2024-0169

Effectiveness of glucagon-like peptide-1 receptor agonists for reduction of body mass index and blood glucose control in patients with type 2 diabetes mellitus and obesity: A retrospective cohort study and difference-in-difference analysis

Autoren: Siriyotha, Sukanya Anothaisintawee, Thunyarat Looareesuwan, Panu et al.

Quelle: Siriyotha, S, Anothaisintawee, T, Looareesuwan, P, Nimitphong, H, McKay, G J, Attia, J & Thakkinstian, A 2024, 'Effectiveness of glucagon-like peptide-1 receptor agonists for reduction of body mass index and blood glucose control in patients with type 2 diabetes mellitus and obesity: A retrospective cohort study and difference-in-difference analysis', BMJ Open, vol. 14, no. 11, e086424. https://doi.org/10.1136/bmjopen-2024-086424

Schlagwörter: Humans, Diabetes Mellitus, Type 2/drug therapy, Retrospective Studies, Male, Glucagon-Like Peptide-1 Receptor/agonists, Female, Middle Aged, Body Mass Index, Hypoglycemic Agents/therapeutic use, Obesity/drug therapy, Blood Glucose/drug effects, Glycated Hemoglobin/analysis, Aged, Glycemic Control/methods, Treatment Outcome, Adult, Glucagon-Like Peptide-1 Receptor Agonists, /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being, name=SDG 3 - Good Health and Well-being

Dateibeschreibung: application/pdf

Verfügbarkeit: https://pure.qub.ac.uk/en/publications/797874b6-a0c2-4382-b2db-d23bb33895ae
https://doi.org/10.1136/bmjopen-2024-086424
https://pureadmin.qub.ac.uk/ws/files/619965501/e086424.full.pdf

Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA): position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA)

Autoren: Chantal Mathieu Martin Tauschmann Emma G. Wilmot et al.

Weitere Verfasser: Chantal Mathieu Martin Tauschmann Emma G. Wilmot et al.

Quelle: Pediatr Diabetes
Moser, Othmar; Riddell, Michael C; Eckstein, Max L; Adolfsson, Peter; Rabasa-Lhoret, Rémi; van den Boom, Louisa; Gillard, Pieter; Nørgaard, Kirsten; Oliver, Nick S; Zaharieva, Dessi P; Battelino, Tadej; de Beaufort, Carine; Bergenstal, Richard M; Buckingham, Bruce; Cengiz, Eda; Deeb, Asma; Heise, Tim; Heller, Simon; Kowalski, Aaron J; Leelarathna, Lalantha; ... (2020). Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA). Diabetologia, 63(12), pp. 2501-2520. Springer 10.1007/s00125-020-05263-9 <http://dx.doi.org/10.1007/s00125-020-05263-9>
Moser, Othmar; Riddell, Michael C; Eckstein, Max L; Adolfsson, Peter; Rabasa-Lhoret, Rémi; van den Boom, Louisa; Gillard, Pieter; Nørgaard, Kirsten; Oliver, Nick S; Zaharieva, Dessi P; Battelino, Tadej; de Beaufort, Carine; Bergenstal, Richard M; Buckingham, Bruce; Cengiz, Eda; Deeb, Asma; Heise, Tim; Heller, Simon; Kowalski, Aaron J; Leelarathna, Lalantha; ... (2020). Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA). Pediatric diabetes, 21(8), pp. 1375-1393. Wiley 10.1111/pedi.13105 <http://dx.doi.org/10.1111/pedi.13105>
Moser, O, Riddell, M C, Eckstein, M L, Adolfsson, P, Rabasa-Lhoret, R, van den Boom, L, Gillard, P, Nørgaard, K, Oliver, N S, Zaharieva, D P, Battelino, T, de Beaufort, C, Bergenstal, R M, Buckingham, B, Cengiz, E, Deeb, A, Heise, T, Heller, S, Kowalski, A J, Leelarathna, L, Mathieu, C, Stettler, C, Tauschmann, M, Thabit, H, Wilmot, E G, Sourij, H, Smart, C E, Jacobs, P G, Bracken, R M & Mader, J K 2020, 'Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes : position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA)', Diabetologia, vol. 63, no. 12, pp. 2501-2520. https://doi.org/10.1007/s00125-020-05263-9
Diabetolegia

Schlagwörter: Blood Glucose, type 1 diabetes, Sustainable Development Goals, physical activity, Position statement, Adolescents, Pediatrics, NOCTURNAL HYPOGLYCEMIA, 0302 clinical medicine, GLYCEMIC CONTROL, Exercise/physiology, CARDIOVASCULAR RISK-FACTORS, adults, Insulin, adolescents, Child, Children, Continuous glucose monitoring, Quality Of Life, SDG 3, exercise, position statement, Diabetes Mellitus, Type 1/physiopathology, Type 1/physiopathology, Adolescents Adults CGM Children Continuous glucose monitoring Exercise Physical activity Position statement Type 1 diabetes, 3. Good health, RAPID-ACTING INSULIN, Type 1 diabetes, continuous glucose monitoring, AEROBIC EXERCISE, Life Sciences & Biomedicine, Adult, Adolescent, Diabetes Mellitus, Type 1/drug therapy, 610 Medicine & health, Glycemic Control, Endocrinology & Metabolism, 03 medical and health sciences, children, Diabetes Mellitus, Adults, Humans, Hypoglycemic Agents, Exercise, POSTEXERCISE HYPERGLYCEMIA, Science & Technology, Blood Glucose/metabolism, Physical activity, CGM, Blood Glucose Self-Monitoring, 3202 Clinical sciences, ADULTS, Hypoglycemic Agents/administration & dosage, 3213 Paediatrics, MODERATE-INTENSITY EXERCISE, PHYSICAL-ACTIVITY, Diabetes Mellitus, Type 1, quality of life, Ispad Guidelines, Quality of Life, 1114 Paediatrics and Reproductive Medicine, Glycemic Control/methods, DEXCOM G4 PLATINUM, Insulin/administration & dosage

Dateibeschreibung: application/pdf

Zugangs-URL: https://link.springer.com/content/pdf/10.1007/s00125-020-05263-9.pdf
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/pedi.13105
https://pubmed.ncbi.nlm.nih.gov/33047481
https://pubmed.ncbi.nlm.nih.gov/33047169
https://research.manchester.ac.uk/en/publications/f24d5dbd-dc0a-4a20-aadc-ee5766c85169
https://doi.org/10.1007/s00125-020-05263-9
https://pubmed.ncbi.nlm.nih.gov/33047481/
https://onlinelibrary.wiley.com/doi/full/10.1111/pedi.13105
https://onlinelibrary.wiley.com/doi/pdf/10.1111/pedi.13105
https://ohsu.pure.elsevier.com/en/publications/glucose-management-for-exercise-using-continuous-glucose-monitori
https://europepmc.org/article/MED/33047481
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7702152/
https://pubmed.ncbi.nlm.nih.gov/33047169/
https://www.ncbi.nlm.nih.gov/pubmed/33047169
https://boris.unibe.ch/149894/
https://link.springer.com/content/pdf/10.1007/s00125-020-05263-9.pdf
https://cronfa.swan.ac.uk/Record/cronfa55487
http://derbyhospitals-nhs.archive.knowledgearc.net/handle/123456789/2339
https://cronfa.swan.ac.uk/Record/cronfa55486/Download/55486__18474__e8c66870c5054c5c93b41efce8ea45f4.pdf
https://cronfa.swan.ac.uk/Record/cronfa55487
https://boris.unibe.ch/148217/
https://boris.unibe.ch/149894/
https://biblio.vub.ac.be/vubir/(58bbfe35-c2f9-4825-a9e6-d9525d0eebed).html
https://biblio.vub.ac.be/vubir/(605f8069-3e66-42b9-9a7f-bbd6a051afc4).html

Implementation Strategies for Inpatient Continuous Glucose Monitoring-based Diabetes Management:A Systematic Review

Autoren: Olsen, Mikkel T Liarakos, Alexandros L Wilmot, Emma G et al.

Quelle: Olsen, M T, Liarakos, A L, Wilmot, E G, Dhatariya, K, Thabit, H, Sánchez-García, D, Nørgaard, K, Pedersen-Bjergaard, U, Hansen, K B, Vangoitsenhoven, R, Mathieu, C, Kristensen, P L & Mader, J K 2025, 'Implementation Strategies for Inpatient Continuous Glucose Monitoring-based Diabetes Management : A Systematic Review', The Journal of Clinical Endocrinology and Metabolism, vol. 110, no. 7, pp. e2411-e2419. https://doi.org/10.1210/clinem/dgaf074

Schlagwörter: Humans, Blood Glucose Self-Monitoring/methods, Blood Glucose/analysis, Inpatients/statistics & numerical data, Diabetes Mellitus/blood, Insulin/administration & dosage, Hypoglycemic Agents/administration & dosage, Glycemic Control/methods, Continuous Glucose Monitoring

Verfügbarkeit: https://research.manchester.ac.uk/en/publications/ae07b615-5316-4911-bfa8-c5b05d3e322b
https://doi.org/10.1210/clinem/dgaf074

Fully closed-loop control with ultra-rapid versus standard insulin lispro:A randomised crossover study simulating missed meal boluses

Autoren: Thabit, Hood Lim, Jonathan Willinska, Malgorzata E et al.

Quelle: Thabit, H, Lim, J, Willinska, M E, Fullwood, C, Hovorka, R & Leelarathna, L 2025, 'Fully closed-loop control with ultra-rapid versus standard insulin lispro : A randomised crossover study simulating missed meal boluses', Diabetic medicine : a journal of the British Diabetic Association, vol. 42, no. 10, pp. e70122. https://doi.org/10.1111/dme.70122

Schlagwörter: Humans, Female, Insulin Lispro/administration & dosage, Cross-Over Studies, Adult, Diabetes Mellitus, Type 1/drug therapy, Male, Hypoglycemic Agents/administration & dosage, Insulin Infusion Systems, Blood Glucose/metabolism, Middle Aged, Meals, Glycated Hemoglobin/metabolism, Glycemic Control/methods, Blood Glucose Self-Monitoring

Verfügbarkeit: https://research.manchester.ac.uk/en/publications/1761444a-fca5-43ab-8c76-b88abb2747f5
https://doi.org/10.1111/dme.70122

Glycogen Storage Disease Type Ia:Current Management Options, Burden and Unmet Needs

Autoren: Derks, Terry G J Rodriguez-Buritica, David F Ahmad, Ayesha et al.

Quelle: Derks, T G J, Rodriguez-Buritica, D F, Ahmad, A, de Boer, F, Couce, M L, Grünert, S C, Labrune, P, López Maldonado, N, Fischinger Moura de Souza, C, Riba-Wolman, R, Rossi, A, Saavedra, H, Gupta, R N, Valayannopoulos, V & Mitchell, J 2021, 'Glycogen Storage Disease Type Ia : Current Management Options, Burden and Unmet Needs', Nutrients, vol. 13, no. 11. https://doi.org/10.3390/nu13113828

Schlagwörter: Cost of Illness, Disease Management, Glycemic Control/methods, Glycogen Storage Disease Type I/complications, Health Services Needs and Demand, Humans, Hypoglycemia/etiology, Kidney/metabolism, Liver/metabolism, Starch/administration & dosage

Dateibeschreibung: application/pdf

Relation: info:eu-repo/semantics/altIdentifier/pmid/34836082; info:eu-repo/semantics/altIdentifier/hdl/https://hdl.handle.net/11370/3db606ff-cf67-4845-8c56-0686b3a8e4ec; info:eu-repo/semantics/altIdentifier/pissn/2072-6643

Verfügbarkeit: https://hdl.handle.net/11370/3db606ff-cf67-4845-8c56-0686b3a8e4ec
https://research.rug.nl/en/publications/3db606ff-cf67-4845-8c56-0686b3a8e4ec
https://doi.org/10.3390/nu13113828
https://pure.rug.nl/ws/files/198974405/Glycogen_Storage_Disease_Type_Ia_Current_Management_Options_Burden_and_Unmet_Needs.pdf
https://www.scopus.com/pages/publications/85118203665

Long-term assessment of the NHS hybrid closed-loop real-world study on glycaemic outcomes, time-in-range, and quality of life in children and young people with type 1 diabetes

Autoren: Ng, Sze May Wright, Neil P Yardley, Diana et al.

Quelle: BMC Medicine vol.22 (2024) date: 2024-04-24 nr.1 [ISSN 1741-7015]

Index Begriffe: Humans, Diabetes Mellitus, Type 1/drug therapy, Quality of Life, Male, Child, Adolescent, Female, Blood Glucose/drug effects, Insulin Infusion Systems, Insulin/administration & dosage, England, Blood Glucose Self-Monitoring/methods, Glycated Hemoglobin/analysis, Hypoglycemic Agents/administration & dosage, Prospective Studies, Hypoglycemia, Glycemic Control/methods, Paediatric, Hybrid-close loop, Diabetes, SDG 3 - Good Health and Well-being, Article (journal)

URL: https://research.edgehill.ac.uk/en/publications/c865c196-2cbf-47dd-a3c6-649a864f2344
https://research.edgehill.ac.uk/ws/files/100627805/s12916-024-03396-x.pdf
https://research.edgehill.ac.uk/ws/files/100627805/s12916-024-03396-x.pdf